A prediction rule for estimating pancreatic cancer risk in chronic pancreatitis patients with focal pancreatic mass lesions with prior negative EUS-FNA cytology

Scandinavian Journal of Gastroenterology

Volumn 46, Issue 4, 2011, Pages 464-470

  Cai, Quan Cai ^a,b   Chen, Yan ^b   Xiao, Yi ^b   Zhu, Wei ^a,b   Xu, Qin Feng ^c   Zhong, Liang ^d   Chen, Shi Yao ^c   Zhang, Min Min ^b   Wang, Luo Wei ^b   Li, Zhao Shen ^a,b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

^d FUDAN UNIVERSITY   (China)

Author keywords

Chronic pancreatitis; pancreatic cancer; prediction rule; risk stratification

Indexed keywords

BILIRUBIN GLUCURONIDE; CA 19-9 ANTIGEN;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; BOOTSTRAPPING; CALIBRATION; CANCER RISK; CHRONIC PANCREATITIS; CONTROLLED STUDY; CYTOLOGY; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC ULTRASOUND GUIDED FINE NEEDLE ASPIRATION; FALSE NEGATIVE RESULT; FEMALE; FOCAL PANCREAS MASS LESION; FOLLOW UP; GENDER AND SEX; HIGH RISK PATIENT; HIGH RISK POPULATION; HUMAN; INVASIVE PROCEDURE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PANCREAS DISEASE; PREDICTION; PREDICTION RULE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SEX DIFFERENCE; STRATIFIED SAMPLE; TUMOR VOLUME;

ADULT; AGED; BILIRUBIN; BIOPSY, FINE-NEEDLE; CA-19-9 ANTIGEN; DIAGNOSIS, DIFFERENTIAL; ENDOSONOGRAPHY; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PANCREATITIS, CHRONIC; PREDICTIVE VALUE OF TESTS; RISK; ROC CURVE; TUMOR BURDEN; ULTRASONOGRAPHY, INTERVENTIONAL; YOUNG ADULT;

EID: 79952605023     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2010.539256     Document Type: Article

References (30)

1. Sahani DV, Shah ZK, Catalano OA, Boland GW, BruggeWR. Radiology of pancreatic adenocarcinoma: current status of imaging. J Gastroenterol Hepatol 2008;23:23-33.
2. Koorstra JB, Hustinx SR, Offerhaus GJ, Maitra A. Pancreatic carcinogenesis. Pancreatology 2008;8:110-25.
3. Albo D, Farrow B, Berger DH. Translation of recent advances and discoveries in molecular biology and immunology in the diagnosis and treatment of pancreatic cancer. Surg Oncol Clin N Am 2008;17:357-76.
4. Farrell JJ. Diagnosing pancreatic malignancy in the setting of chronic pancreatitis: is there room for improvement? Gastrointest Endosc 2005;62:737-41.
5. McKay CJ, Glen P, McMillan DC. Chronic inflammation and pancreatic cancer. Best Pract Res Clin Gastroenterol 2008;22:65-73.
6. Eloubeidi MA, Jhala D, Chhieng DC, Chen VK, Eltoum I, Vickers S, et al. Yield of endoscopic ultrasound-guided fineneedle aspiration biopsy in patients with suspected pancreatic carcinoma. Cancer 2003;99:285-92.
7. Gress F, Gottlieb K, Sherman S, Lehman G. Endoscopic ultrasonography- guided fine-needle aspiration biopsy of suspected pancreatic cancer. Ann Intern Med 2001;134:459-64.
8. Harewood GC, Wiersema MJ. Endosonography-guided fine needle aspiration biopsy in the evaluation of pancreatic masses. Am J Gastroenterol 2002;97:1386-91.
9. Agarwal B, Krishna NB, Labundy JL, Safdar R, Akduman EI. EUS and/or EUS-guided FNA in patients with CT and/or magnetic resonance imaging findings of enlarged pancreatic head or dilated pancreatic duct with or without a dilated common bile duct. Gastrointest Endosc 2008;68:237-42.
10. Krishna NB, Mehra M, Reddy AV, Agarwal B. EUS/EUSFNA for suspected pancreatic cancer: influence of chronic pancreatitis and clinical presentation with or without obstructive jaundice on performance characteristics. Gastrointest Endosc 2009;70:70-9.
11. Fritscher-Ravens A, Brand L, Knöfel WT, Bobrowski C, Topalidis T, Thonke F, et al. Comparison of endoscopic ultrasound-guided fine needle aspiration for focal pancreatic lesions in patients with normal parenchyma and chronic pancreatitis. Am J Gastroenterol 2002;97:2768-75.
12. Iordache S, Saftoiu A, Cazacu S,Gheonea DI,DumitrescuD, Popescu C, et al. Endoscopic ultrasound approach of pancreatic cancer in chronic pancreatitis patients in a tertiary referral centre. J Gastrointestin Liver Dis 2008;17:279-84.
13. Varadarajulu S, Tamhane A, Eloubeidi MA. Yield of EUSguided FNA of pancreatic masses in the presence or the absence of chronic pancreatitis. Gastrointest Endosc 2005; 62:728-36.
14. Ardengh JC, Lopes CV, Campos AD, Pereira de Lima LF, Venco F, Módena JL. Endoscopic ultrasound and fine needle aspiration in chronic pancreatitis: differential diagnosis between pseudotumoral masses and pancreatic cancer. JOP 2007;8:413-21.
15. Bhutani MS, Gress FG, Giovannini M, Erickson RA, Catalano MF, Chak A, et al. The No Endosonographic Detection of Tumor (NEST) Study: a case series of pancreatic cancers missed on endoscopic ultrasonography. Endoscopy 2004;36:385-9.
16. Hollerbach S, Klamann A, Topalidis T, Schmiegel WH. Endoscopic ultrasonography (EUS) and fine-needle aspiration (FNA) cytology for diagnosis of chronic pancreatitis. Endoscopy 2001;33:824-31.
17. Sahai AV. EUS and chronic pancreatitis. Gastrointest Endosc 2002;56:S76-81.
18. Adler DG, Lichtenstein D, Baron TH, Davila R, Egan JV, Gan SL, et al. The role of endoscopy in patients with chronic pancreatitis. Gastrointest Endosc 2006;63:933-7.
19. Sahai AV, Zimmerman M, Aabakken L, Tarnasky PR, Cunningham JT, van Velse A, et al. Prospective assessment of the ability of endoscopic ultrasound to diagnose, exclude, or establish the severity of chronic pancreatitis found by endoscopic retrograde cholangiopancreatography. Gastrointest Endosc 1998;48:18-25.
20. Catalano MF, Lahoti S, Geenen JE, Hogan WJ. Prospective evaluation of endoscopic ultrasonography, endoscopic retrograde pancreatography, and secretin test in the diagnosisof chronic pancreatitis. Gastrointest Endosc 1998;48: 11-17.
21. Hosmer DW, Lemeshow S. Applied logistic regression. 2nd ed. New York: John Willey & Sons; 2000.
22. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29-36.
23. Moons KG, Harrell FE, Steyerberg EW. Should scoring rules be based on odds ratios or regression coefficients? J Clin Epidemiol 2002;55:1054-5.
24. Steyerberg EW, Bleeker SE, Moll HA, Grobbee DE, Moons KG. Internal and external validation of predictive models: a simulation study of bias and precision in small samples. J Clin Epidemiol 2003;56:441-7.
25. Steyerberg EW, Harrell Jr FE, Borsboom GJ, Eijkemans MJ, Vergouwe Y, Habbema JD. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol 2001;54:774-81.
26. Tessler DA, Catanzaro A, Velanovich V, Havstad S, Goel S. Predictors of cancer in patients with suspected pancreatic malignancy without a tissue diagnosis. Am J Surg 2006;191: 191-7.
27. Lee H, Lee JK, Kang SS, Choi D, Jang KT, Kim JH, et al. Is there any clinical or radiologic feature as a preoperative marker for differentiating mass-forming pancreatitis from early-stage pancreatic adenocarcinoma? Hepatogastroenterology 2007;54:2134-40.
28. Bloomston M, Bekaii-Saab TS, Kosuri K, Cowgill SM, Melvin WS, Ellison EC, et al. Preoperative carbohydrate antigen 19-9 is most predictive of malignancy in older jaundiced patients undergoing pancreatic resection. Pancreas 2006;33:246-9.
29. Spier BJ, Johnson EA, Gopal DV, Frick T, Einstein MM, Byrne S, et al. Predictors of malignancy and recommended follow-up in patients with negative endoscopic ultrasoundguided fine-needle aspiration of suspected pancreatic lesions. Can J Gastroenterol 2009;23:279-86.
30. Rodriguez S, Faigel D. Absence of a dilated duct predicts benign disease in suspected pancreas cancer: a simple clinical rule. Dig Dis Sci 2010;55:1161-6.